JP2010507388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010507388A5 JP2010507388A5 JP2009534057A JP2009534057A JP2010507388A5 JP 2010507388 A5 JP2010507388 A5 JP 2010507388A5 JP 2009534057 A JP2009534057 A JP 2009534057A JP 2009534057 A JP2009534057 A JP 2009534057A JP 2010507388 A5 JP2010507388 A5 JP 2010507388A5
- Authority
- JP
- Japan
- Prior art keywords
- prostate cancer
- marker
- allele
- diagnosed
- polymorphic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003550 marker Substances 0.000 claims 21
- 238000000034 method Methods 0.000 claims 16
- 108700028369 Alleles Proteins 0.000 claims 13
- 206010060862 Prostate cancer Diseases 0.000 claims 13
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 13
- 208000035392 hereditary 6 prostate cancer Diseases 0.000 claims 7
- 208000032154 hereditary 8 prostate cancer Diseases 0.000 claims 7
- 102000054766 genetic haplotypes Human genes 0.000 claims 6
- 239000000523 sample Substances 0.000 claims 5
- 239000013068 control sample Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000035945 sensitivity Effects 0.000 claims 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000003205 genotyping method Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002751 oligonucleotide probe Substances 0.000 claims 1
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8560 | 2006-10-27 | ||
| IS8560 | 2006-10-27 | ||
| PCT/IS2007/000019 WO2008050356A1 (en) | 2006-10-27 | 2007-10-26 | Cancer susceptibility variants on chr8q24.21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010507388A JP2010507388A (ja) | 2010-03-11 |
| JP2010507388A5 true JP2010507388A5 (enExample) | 2011-01-27 |
| JP5631000B2 JP5631000B2 (ja) | 2014-11-26 |
Family
ID=39060300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009534057A Expired - Fee Related JP5631000B2 (ja) | 2006-10-27 | 2007-10-26 | Ｃｈｒ８ｑ２４．２１上の癌感受性変異体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100129799A1 (enExample) |
| EP (1) | EP2089548A1 (enExample) |
| JP (1) | JP5631000B2 (enExample) |
| CN (1) | CN101641451A (enExample) |
| AU (1) | AU2007310412B2 (enExample) |
| BR (1) | BRPI0718322A2 (enExample) |
| CA (1) | CA2667737A1 (enExample) |
| IL (1) | IL198305A0 (enExample) |
| MX (1) | MX2009004522A (enExample) |
| NZ (1) | NZ576591A (enExample) |
| SG (1) | SG175680A1 (enExample) |
| WO (1) | WO2008050356A1 (enExample) |
| ZA (1) | ZA200903173B (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| CA2677994A1 (en) * | 2007-02-07 | 2008-08-14 | Decode Genetics Ehf. | Genetic variants contributing to risk of prostate cancer |
| EP2548961A1 (en) | 2007-04-17 | 2013-01-23 | Santen Pharmaceutical Co., Ltd | Method for determination of progression risk of glaucoma |
| US8697360B2 (en) * | 2007-11-30 | 2014-04-15 | Decode Genetics Ehf. | Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition |
| US20090226912A1 (en) * | 2007-12-21 | 2009-09-10 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| CA2729934A1 (en) * | 2008-07-07 | 2010-01-14 | Decode Genetics Ehf | Genetic variants for breast cancer risk assessment |
| US8583380B2 (en) | 2008-09-05 | 2013-11-12 | Aueon, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| WO2010045318A2 (en) * | 2008-10-14 | 2010-04-22 | Caris Mpi, Inc. | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| EP2451975A4 (en) * | 2009-05-08 | 2013-08-14 | Decode Genetics Ehf | GENETIC VARIANTS CONTRIBUTING TO A RISK OF PROSTATE CANCER |
| WO2011004404A1 (en) * | 2009-07-10 | 2011-01-13 | Decode Genetics Ehf | Genetic variants for predicting risk of glaucoma |
| US20120316218A1 (en) * | 2009-07-17 | 2012-12-13 | Glinsky Gennadi V | SMALL NON-CODING REGULARTORY RNA's and METHODS FOR THEIR USE |
| WO2011009089A1 (en) * | 2009-07-17 | 2011-01-20 | Ordway Research Institute, Inc. | SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE |
| CA2777169C (en) | 2009-10-26 | 2018-11-20 | Abbott Laboratories | Diagnostic methods for determining prognosis of non-small cell lung cancer |
| RU2012121874A (ru) | 2009-10-26 | 2013-12-10 | Эбботт Лэборетриз | Диагностические способы для определения прогноза немелкоклеточного рака легкого |
| WO2012029080A1 (en) * | 2010-08-30 | 2012-03-08 | Decode Genetics Ehf | Sequence variants associated with prostate specific antigen levels |
| US9732389B2 (en) | 2010-09-03 | 2017-08-15 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| CN103228798B (zh) | 2010-09-24 | 2015-12-09 | 斯坦福大学托管董事会 | 使用固定的引物直接捕获、扩增及测序靶标dna |
| US9534256B2 (en) | 2011-01-06 | 2017-01-03 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer |
| CN103562407A (zh) * | 2011-02-09 | 2014-02-05 | 伯乐生命医学产品有限公司 | 核酸的分析 |
| CN102304567B (zh) * | 2011-04-29 | 2013-03-27 | 广州益善生物技术有限公司 | 一种染色体8q24区段多态性检测特异性引物和液相芯片 |
| WO2012178058A1 (en) * | 2011-06-22 | 2012-12-27 | Indiana University Research And Technology Corporation | Compositions for and methods of detecting, diagnosing and prognosing thymic cancer |
| WO2013065072A1 (en) * | 2011-10-30 | 2013-05-10 | Decode Genetics Ehf | Risk variants of prostate cancer |
| EP3024948B1 (en) | 2013-07-25 | 2020-01-15 | Bio-rad Laboratories, Inc. | Genetic assays for detecting viral recombination rate |
| CN108292326B (zh) * | 2015-08-27 | 2022-04-01 | 皇家飞利浦有限公司 | 用于识别功能性患者特异性体细胞畸变的整合方法和系统 |
| WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| KR101944927B1 (ko) | 2016-03-24 | 2019-02-07 | 서울대학교산학협력단 | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
| CN106480211A (zh) * | 2016-11-24 | 2017-03-08 | 深圳市核子基因科技有限公司 | 一种用于检测睾丸癌易感性的试剂盒及其snp标志物 |
| WO2018141828A1 (en) * | 2017-02-01 | 2018-08-09 | Phadia Ab | Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics |
| TW202033760A (zh) * | 2018-11-28 | 2020-09-16 | 國立大學法人千葉大學 | 多因素遺傳疾病的基因檢測法、及檢測套件 |
| WO2020223657A1 (en) * | 2019-05-02 | 2020-11-05 | Predictive Technology Group, Inc. | Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk |
| WO2021178832A2 (en) * | 2020-03-06 | 2021-09-10 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Dna damage repair genes in cancer |
| KR102177222B1 (ko) * | 2020-04-24 | 2020-11-10 | 유니젠바이오 주식회사 | 머신러닝 기반 암진단 예측 시스템 |
| KR102177218B1 (ko) * | 2020-04-24 | 2020-11-10 | 유니젠바이오 주식회사 | 머신러닝 기반 암진단 예측 장치 |
| KR20250074712A (ko) | 2023-11-15 | 2025-05-28 | 주식회사 바스젠바이오 | 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5384261A (en) * | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| AU785425B2 (en) * | 2001-03-30 | 2007-05-17 | Genetic Technologies Limited | Methods of genomic analysis |
| AU2002324649A1 (en) * | 2001-08-04 | 2003-02-24 | General Hospital Corporation | Haplotype map of the human genome and uses therefor |
| US20040023237A1 (en) * | 2001-11-26 | 2004-02-05 | Perelegen Sciences Inc. | Methods for genomic analysis |
| US20040146870A1 (en) * | 2003-01-27 | 2004-07-29 | Guochun Liao | Systems and methods for predicting specific genetic loci that affect phenotypic traits |
-
2007
- 2007-10-26 WO PCT/IS2007/000019 patent/WO2008050356A1/en not_active Ceased
- 2007-10-26 BR BRPI0718322-4A2A patent/BRPI0718322A2/pt not_active IP Right Cessation
- 2007-10-26 US US12/442,254 patent/US20100129799A1/en not_active Abandoned
- 2007-10-26 CN CN200780046943A patent/CN101641451A/zh active Pending
- 2007-10-26 NZ NZ576591A patent/NZ576591A/en not_active IP Right Cessation
- 2007-10-26 MX MX2009004522A patent/MX2009004522A/es active IP Right Grant
- 2007-10-26 CA CA002667737A patent/CA2667737A1/en not_active Abandoned
- 2007-10-26 SG SG2011078417A patent/SG175680A1/en unknown
- 2007-10-26 EP EP20070827611 patent/EP2089548A1/en not_active Withdrawn
- 2007-10-26 JP JP2009534057A patent/JP5631000B2/ja not_active Expired - Fee Related
- 2007-10-26 AU AU2007310412A patent/AU2007310412B2/en not_active Ceased
-
2009
- 2009-04-22 IL IL198305A patent/IL198305A0/en unknown
- 2009-05-07 ZA ZA2009/03173A patent/ZA200903173B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010507388A5 (enExample) | ||
| JP2011530306A5 (enExample) | ||
| JP2010527603A5 (enExample) | ||
| JP2010520745A5 (enExample) | ||
| Zhang et al. | Comprehensive one-step molecular analyses of mitochondrial genome by massively parallel sequencing | |
| Coulombe-Huntington et al. | Fine-scale variation and genetic determinants of alternative splicing across individuals | |
| JP2010533477A5 (enExample) | ||
| JP2010522555A5 (enExample) | ||
| JP2010518848A5 (enExample) | ||
| JP2008546403A5 (enExample) | ||
| CA2511042A1 (en) | Association of single nucleotide polymorphisms in ppar.gamma. with osteoporosis | |
| JP2017529859A (ja) | 乳癌発症リスクを評価する方法 | |
| JP2011520433A5 (enExample) | ||
| EP3332031B1 (en) | Snp rs12603226 as a predictive marker for nafld | |
| RU2016131167A (ru) | Способы лечения, диагностики и мониторинга волчанки | |
| JP2010510804A5 (enExample) | ||
| JP2013544536A5 (enExample) | ||
| TW202438680A (zh) | 可實施２種以上檢測的遺傳學分析方法 | |
| JP5807894B2 (ja) | 一塩基多型に基づく前立腺癌の検査方法 | |
| KR101536213B1 (ko) | 복부비만 예측용 ｓｎｐ 마커 및 이의 용도 | |
| JP5721150B2 (ja) | 加齢黄斑変性症の発症リスクの予測方法 | |
| KR101532308B1 (ko) | 복부비만 예측용 ｓｎｐ 마커 및 이의 용도 | |
| CN109182490B (zh) | Lrsam1基因snp突变位点分型引物及其在冠心病预测中的应用 | |
| US20160053333A1 (en) | Novel Haplotype Tagging Single Nucleotide Polymorphisms and Use of Same to Predict Childhood Lymphoblastic Leukemia | |
| KR102346185B1 (ko) | 피부 색소 침착 위험도 예측용 바이오마커 및 이의 용도 |